Chemed
425 hedge funds and large institutions have $6.79B invested in Chemed in 2022 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 150 increasing their positions, 136 reducing their positions, and 41 closing their positions.
672% more call options, than puts
Call options by funds: $7.04M | Put options by funds: $912K
24% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 41
10% more repeat investments, than reductions
Existing positions increased: 150 | Existing positions reduced: 136
1.81% more ownership
Funds ownership: 88.02% → 89.83% (+1.8%)
1% more funds holding
Funds holding: 420 → 425 (+5)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
5% less capital invested
Capital invested by funds: $7.12B → $6.79B (-$330M)
Top Buyers
Top Sellers
CHE Hedge Fund Activity: Q1 2022 in Review
425 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q1 2022, worth a combined $6.79B — down 4.6% from $7.12B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new CHE positions and 41 closed out — a net gain of 10 holders — while 150 added to existing stakes and 136 trimmed.
The largest buyer was Invesco, adding an estimated $52.2M. The largest seller was Capital World Investors, cutting an estimated $101M.
- 425 institutional investors held Chemed (CHE) as of Q1 2022, up from 420 in Q4 2021.
- Funds reported $6.79B of Chemed stock for Q1 2022, down 4.6% quarter-over-quarter.
- 51 funds opened new Chemed positions in Q1 2022 and 41 closed out, a net change of +10 holders.
- The largest Chemed buyer in Q1 2022 was Invesco, an estimated $52.2M added.
- The largest Chemed seller in Q1 2022 was Capital World Investors, an estimated $101M sold.
Based on aggregated 13F filings for Q1 2022.